Interfering with this metabolism by blocking the catabolism of heme via heme oxygenase-1 (HO-1) inhibition reduced the immunosuppressive activity of BMDMs from patients with glioblastoma (59). This evidence concerns the gene HMOX1 and glioblastoma.